A Eusebio López-Hernández, Carmen Miquel-López, José Javier García-Medina, Diego García-Ayuso
{"title":"注意力缺陷/多动症患者与视觉相关的生活质量和近工作视觉症状。","authors":"A Eusebio López-Hernández, Carmen Miquel-López, José Javier García-Medina, Diego García-Ayuso","doi":"10.1080/08164622.2024.2422473","DOIUrl":null,"url":null,"abstract":"<p><strong>Clinical relevance: </strong>Attention-deficit/hyperactivity disorder (ADHD) has been associated with visual symptoms that may impact daily activities such as near-work tasks and social interactions. Addressing these visual issues is important for improving the overall quality of life and functional outcomes in individuals with ADHD, particularly in academic and social settings.</p><p><strong>Purpose: </strong>To investigate the relationship between vision-related quality of life and near-work visual symptoms in patients with ADHD patients.</p><p><strong>Methods: </strong>A cohort of 37 individuals with ADHD was compared to age- and sex-matched healthy controls (<i>n</i> = 37). The 25-Item National Eye Institute Visual Function Questionnaire (NEI VFQ-25) and the Convergence Insufficiency Symptoms Survey (CISS) were used to assess vision-related quality of life and near-work visual symptoms.</p><p><strong>Results: </strong>Mean NEI VFQ-25 scores were not significantly different between the ADHD and control groups. However, individuals with ADHD scored lower on the near activities (<i>p</i> = 0.032; Cohen's d = -0.511), social functioning (<i>p</i> = 0.045; Cohen's d = -0.481) and driving (<i>p</i> = 0.007; Cohen's d = -0.124) subscales. The CISS scores were significantly higher in the ADHD group (23.43 ± 11.22) than in the control group (14.02 ± 9.36; <i>p</i> < 0.001; Cohen's d = 0.910), indicating a significant relationship between ADHD and the presence of symptomatic subjects (<i>p</i> < 0.001; Cramer's V = 0.541). Medication did not affect NEI VFQ-25 or CISS scores. Female gender was associated with an increased number of symptomatic subjects based on their CISS scores (<i>p</i> = 0.043; Cramer's V = 0.396). Symptomatic ADHD individuals had lower NEI VFQ-25 scores (85.02 ± 12.68 vs. 96.02 ± 4.63, <i>p</i> = 0.008; Cohen's d = -0.969), indicating compromised vision-related quality of life.</p><p><strong>Conclusions: </strong>Patients with ADHD experienced a reduced vision-related quality of life and increased near-work visual symptoms, suggesting potential repercussions on academic performance and social adaptability. This study underscores the importance of addressing visual issues in the ADHD population to enhance their overall well-being and functional outcomes.</p>","PeriodicalId":10214,"journal":{"name":"Clinical and Experimental Optometry","volume":" ","pages":"830-837"},"PeriodicalIF":1.5000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Vision-related quality of life and near-work visual symptoms in patients with attention-deficit/hyperactivity disorder.\",\"authors\":\"A Eusebio López-Hernández, Carmen Miquel-López, José Javier García-Medina, Diego García-Ayuso\",\"doi\":\"10.1080/08164622.2024.2422473\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Clinical relevance: </strong>Attention-deficit/hyperactivity disorder (ADHD) has been associated with visual symptoms that may impact daily activities such as near-work tasks and social interactions. Addressing these visual issues is important for improving the overall quality of life and functional outcomes in individuals with ADHD, particularly in academic and social settings.</p><p><strong>Purpose: </strong>To investigate the relationship between vision-related quality of life and near-work visual symptoms in patients with ADHD patients.</p><p><strong>Methods: </strong>A cohort of 37 individuals with ADHD was compared to age- and sex-matched healthy controls (<i>n</i> = 37). The 25-Item National Eye Institute Visual Function Questionnaire (NEI VFQ-25) and the Convergence Insufficiency Symptoms Survey (CISS) were used to assess vision-related quality of life and near-work visual symptoms.</p><p><strong>Results: </strong>Mean NEI VFQ-25 scores were not significantly different between the ADHD and control groups. However, individuals with ADHD scored lower on the near activities (<i>p</i> = 0.032; Cohen's d = -0.511), social functioning (<i>p</i> = 0.045; Cohen's d = -0.481) and driving (<i>p</i> = 0.007; Cohen's d = -0.124) subscales. The CISS scores were significantly higher in the ADHD group (23.43 ± 11.22) than in the control group (14.02 ± 9.36; <i>p</i> < 0.001; Cohen's d = 0.910), indicating a significant relationship between ADHD and the presence of symptomatic subjects (<i>p</i> < 0.001; Cramer's V = 0.541). Medication did not affect NEI VFQ-25 or CISS scores. Female gender was associated with an increased number of symptomatic subjects based on their CISS scores (<i>p</i> = 0.043; Cramer's V = 0.396). Symptomatic ADHD individuals had lower NEI VFQ-25 scores (85.02 ± 12.68 vs. 96.02 ± 4.63, <i>p</i> = 0.008; Cohen's d = -0.969), indicating compromised vision-related quality of life.</p><p><strong>Conclusions: </strong>Patients with ADHD experienced a reduced vision-related quality of life and increased near-work visual symptoms, suggesting potential repercussions on academic performance and social adaptability. This study underscores the importance of addressing visual issues in the ADHD population to enhance their overall well-being and functional outcomes.</p>\",\"PeriodicalId\":10214,\"journal\":{\"name\":\"Clinical and Experimental Optometry\",\"volume\":\" \",\"pages\":\"830-837\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical and Experimental Optometry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/08164622.2024.2422473\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/11/17 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Optometry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/08164622.2024.2422473","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/17 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
临床意义:注意力缺陷/多动障碍(ADHD)与视觉症状有关,这些症状可能会影响日常活动,如近距离工作任务和社会交往。解决这些视觉问题对于提高多动症患者的整体生活质量和功能结果非常重要,尤其是在学习和社交环境中。目的:研究多动症患者的视觉相关生活质量与近工作视觉症状之间的关系:方法:将 37 名多动症患者与年龄和性别匹配的健康对照组(37 人)进行比较。采用 25 项国家眼科研究所视觉功能问卷(NEI VFQ-25)和会聚障碍症状调查(CISS)来评估与视觉相关的生活质量和近工作视觉症状:多动症组和对照组的 NEI VFQ-25 平均得分没有明显差异。然而,多动症患者在近距离活动(p = 0.032;Cohen's d = -0.511)、社会功能(p = 0.045;Cohen's d = -0.481)和驾驶(p = 0.007;Cohen's d = -0.124)分量表上的得分较低。多动症组的 CISS 分数(23.43 ± 11.22)明显高于对照组(14.02 ± 9.36;p < 0.001;Cohen's d = 0.910),这表明多动症与有症状的受试者之间存在显著关系(p < 0.001;Cramer's V = 0.541)。药物治疗并不影响 NEI VFQ-25 或 CISS 分数。根据 CISS 分数,女性性别与症状受试者人数增加有关(p = 0.043;Cramer's V = 0.396)。有症状的多动症患者的NEI VFQ-25得分较低(85.02 ± 12.68 vs. 96.02 ± 4.63,p = 0.008;Cohen's d = -0.969),这表明与视力相关的生活质量受到了影响:结论:多动症患者的视力相关生活质量下降,近距离工作视觉症状增加,这可能会影响学习成绩和社会适应能力。这项研究强调了解决多动症患者的视觉问题以提高他们的整体健康和功能结果的重要性。
Vision-related quality of life and near-work visual symptoms in patients with attention-deficit/hyperactivity disorder.
Clinical relevance: Attention-deficit/hyperactivity disorder (ADHD) has been associated with visual symptoms that may impact daily activities such as near-work tasks and social interactions. Addressing these visual issues is important for improving the overall quality of life and functional outcomes in individuals with ADHD, particularly in academic and social settings.
Purpose: To investigate the relationship between vision-related quality of life and near-work visual symptoms in patients with ADHD patients.
Methods: A cohort of 37 individuals with ADHD was compared to age- and sex-matched healthy controls (n = 37). The 25-Item National Eye Institute Visual Function Questionnaire (NEI VFQ-25) and the Convergence Insufficiency Symptoms Survey (CISS) were used to assess vision-related quality of life and near-work visual symptoms.
Results: Mean NEI VFQ-25 scores were not significantly different between the ADHD and control groups. However, individuals with ADHD scored lower on the near activities (p = 0.032; Cohen's d = -0.511), social functioning (p = 0.045; Cohen's d = -0.481) and driving (p = 0.007; Cohen's d = -0.124) subscales. The CISS scores were significantly higher in the ADHD group (23.43 ± 11.22) than in the control group (14.02 ± 9.36; p < 0.001; Cohen's d = 0.910), indicating a significant relationship between ADHD and the presence of symptomatic subjects (p < 0.001; Cramer's V = 0.541). Medication did not affect NEI VFQ-25 or CISS scores. Female gender was associated with an increased number of symptomatic subjects based on their CISS scores (p = 0.043; Cramer's V = 0.396). Symptomatic ADHD individuals had lower NEI VFQ-25 scores (85.02 ± 12.68 vs. 96.02 ± 4.63, p = 0.008; Cohen's d = -0.969), indicating compromised vision-related quality of life.
Conclusions: Patients with ADHD experienced a reduced vision-related quality of life and increased near-work visual symptoms, suggesting potential repercussions on academic performance and social adaptability. This study underscores the importance of addressing visual issues in the ADHD population to enhance their overall well-being and functional outcomes.
期刊介绍:
Clinical and Experimental Optometry is a peer reviewed journal listed by ISI and abstracted by PubMed, Web of Science, Scopus, Science Citation Index and Current Contents. It publishes original research papers and reviews in clinical optometry and vision science. Debate and discussion of controversial scientific and clinical issues is encouraged and letters to the Editor and short communications expressing points of view on matters within the Journal''s areas of interest are welcome. The Journal is published six times annually.